Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapy. [PDF]
Sun H +19 more
europepmc +1 more source
The Evolving Landscape of Immune Regulation and Immunotherapy in Cholangiocarcinoma and Biliary Tract Cancer. [PDF]
Rizk E, Foley P, Osataphan S.
europepmc +1 more source
Translational and Implementation Barrier in the Management of Biliary Tract Cancer: Diagnostic, Molecular, Therapeutic, and Patient-Centered Challenges. [PDF]
Bukhari RZ, Li Z, Li F, Hu H.
europepmc +1 more source
Exosome-Based Liquid Biopsy in Biliary Tract Cancer: Nanotechnology-Enabled Strategies and Future Perspectives. [PDF]
Choi Y +7 more
europepmc +1 more source
Association Between Cumulative Chemotherapy Exposure and Survival Outcomes in Advanced Biliary Tract Cancer. [PDF]
Nguyen VK +16 more
europepmc +1 more source
Global patterns of mutational profiles in biliary tract cancer. [PDF]
Zhu Y +9 more
europepmc +1 more source
Treatment of biliary tract cancer - essentials for clinical practice. [PDF]
Liberko M, Soumarova R.
europepmc +1 more source
A Phase II Multicenter Trial of Rucaparib and Nivolumab as Maintenance Therapy in Patients with Advanced Biliary Tract Cancer: BilT-02. [PDF]
Mohan A +16 more
europepmc +1 more source

